P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING

• M. Grimley,
• M. Kent,
• M. Asnani,
• A. Shrestha,
• S. Felker,
• C. Lutzko,
• P. Arumugam,
• S. Witting,
• J. Knight-Madden,
• O. Niss,
• C. Quinn,
• C. Lo,
• C. Little,
• A. Dong,
• P. Malik

Affiliations

M. Grimley

1 Cincinnati Children’s Hospital Medical Center, Cincinnati

M. Kent

2 Atrium Health Levine Children’s Hospital, Charlotte, United States of America

M. Asnani

3 Caribbean Institute for Health Research, Kingston, Jamaica

A. Shrestha

4 Aruvant Sciences, New York, United States of America

S. Felker

1 Cincinnati Children’s Hospital Medical Center, Cincinnati

C. Lutzko

1 Cincinnati Children’s Hospital Medical Center, Cincinnati

P. Arumugam

1 Cincinnati Children’s Hospital Medical Center, Cincinnati

S. Witting

1 Cincinnati Children’s Hospital Medical Center, Cincinnati

J. Knight-Madden

3 Caribbean Institute for Health Research, Kingston, Jamaica

O. Niss

1 Cincinnati Children’s Hospital Medical Center, Cincinnati

C. Quinn

1 Cincinnati Children’s Hospital Medical Center, Cincinnati

C. Lo

4 Aruvant Sciences, New York, United States of America

C. Little

4 Aruvant Sciences, New York, United States of America

A. Dong

4 Aruvant Sciences, New York, United States of America

P. Malik

1 Cincinnati Children’s Hospital Medical Center, Cincinnati